Fairly good results, IMO. But, it's still in early stages of testing. I honestly don't see much upside for a while. Anything can happen in Phase 2/Phase 3 trials. If you would be holding them for several years, it could possibly be a good long-term play though, IMO.
GL!
Visit my biotech investing board!: investorshub.advfn.com/boards/board.aspx?board_id=16653
GLTA.